The Chlordiazepoxide Hydrochloride a, cataloged under National Stock Number 6505-01-025-8575, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Hoffmann-La Roche Inc.. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 4 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-025-8575 |
| Primary Part Number | 75525 |
| Item Name | Chlordiazepoxide Hydrochloride a |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Hoffmann-La Roche Inc. |
| Status | ACTIVE |
| Capsule Primary Container Content Quantity | 90.000 |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| Capsule Content Form | POWDER |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 75525 PRIMARY | Hoffmann-La Roche Inc. (USA) |
| NDC00879-0501-09 PRIMARY | Halsey Drug Co Inc (USA) |
| NDC00140-0007-52 PRIMARY | Hoffmann-La Roche Inc. (USA) |
NSN 6505-01-025-8575 is a Chlordiazepoxide Hydrochloride a, manufactured by Hoffmann-La Roche Inc., classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-025-8575 has 3 cross-referenced part numbers: 75525 (Hoffmann-La Roche Inc.), NDC00879-0501-09 (Halsey Drug Co Inc), NDC00140-0007-52 (Hoffmann-La Roche Inc.).
There are 4 known substitutes for 6505-01-025-8575: 5315-00-530-3605, 5120-00-797-2405, 4720-01-342-6370 and 1 more. Verify interchangeability with system specifications before substitution.
Key specifications for 75525: Capsule Primary Container Content Quantity: 90.000; Active Medicament Medicinal Strength: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT; Capsule Content Form: POWDER; Primary Container Type: BOTTLE. 4 total characteristics are documented in the Federal Logistics Information System.